Haverford Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6,229
Closed -$210K 87
2018
Q1
$210K Sell
6,229
-3,780
-38% -$130K 0.08% 86
2017
Q4
$344K Buy
10,009
+406
+4% +$13.8K 0.13% 62
2017
Q3
$325K Hold
9,603
0.13% 56
2017
Q2
$306K Sell
9,603
-157
-2% -$4.95K 0.12% 46
2017
Q1
$317K Sell
9,760
-52
-0.5% -$1.64K 0.13% 44
2016
Q4
$302K Hold
9,812
0.13% 45
2016
Q3
$315K Buy
9,812
+161
+2% +$5.38K 0.14% 43
2016
Q2
$322K Buy
9,651
+793
+9% +$25.3K 0.14% 46
2016
Q1
$249K Buy
+8,858
New +$253K 0.11% 55

Other funds holding PFE

Haverford Financial Services's PFE Position: Q2 2018 in Review

Haverford Financial Services sold out of Pfizer (PFE) in Q2 2018, closing a stake of 6,229 shares — an estimated $210K sold.

Haverford Financial Services first reported a position in PFE in Q1 2016 and held it in 9 quarters. The position peaked at $344K in Q4 2017. 2,205 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Haverford Financial Services reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Haverford Financial Services sold 6,229 Pfizer shares in Q2 2018, an estimated $210K.
  • Haverford Financial Services first reported a position in Pfizer in Q1 2016 and held it in 9 quarters.
  • Haverford Financial Services's Pfizer position peaked at $344K in Q4 2017.
  • 2,205 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Haverford Financial Services's 13F filing for Q2 2018, filed 10 Aug 2018.